The private placement includes participation from several leading healthcare investors including ADAR1 Capital, Ikarian Capital, Stonepine Capital Management and Nazare PartnersProceeds expected to ...
TURKU, FI / ACCESS Newswire / May 4, 2026 / The annual general meeting ("AGM") of Faron Pharmaceuticals Ltd (LSE:FARN)(First North:FARON) took place in Turku, Finland, today 4 May 2026. Thirty-nine ...
Valerio Therapeutics (FR0010095596 – ALVIO), a biotechnology company specializing in the development of technology platforms dedicated to the targeted delivery of innovative therapies (the “Company”), ...
Integrant today announced the formal publication of its proprietary “CTC Formula” in Chaos to Creation, (ISBN9798255688227) marking the first time the framework has been made accessible to the public, ...
Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelinesCollaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D ...
Two River, LLC (“Two River”) and Vida Ventures (“Vida”), both part of the Bellco Health ecosystem, today acknowledged the announced acquisition of Candid Therapeutics (“Candid”), a privately held ...
Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics ...
Opinion
CMS EXPOSED: The "Workaround Doctrine" - How Matt Zorn's Legal CMS Hemp Strategy Undermines the FDA
Matthew C. Zorn previously argued that federal regulators determine "accepted medical use" through the FDA approval framework. Today, he appears on behalf of the United States defending a CMS program ...
The first consumer experiences powered by true molecular medicine infrastructure are now live at lite.dendrite.com. Take a quiz built from your own genome. Read the seven-chapter story of your biology ...
Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per monthBrief Summary:GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per ...
Oral argument heard Friday, May 1, 2026 in Smart Approaches to Marijuana v. Kennedy — with Ilya Shapiro arguing for ...
TaeWoong Medical USA today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Niti-S SPAXUS™ Stent, further strengthening its portfolio of endoscopic ultrasound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results